Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Daiichi-Sankyo
Company Monitoring Page for Daiichi-Sankyo
latest headlines for company on cafepharma
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Tags:
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
stomach cancer
,
colorectal cancer
,
lung cancer
,
ASCO 2020
AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week
Pharmaforum
Mon, 05/18/20 - 10:49 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
Enhertus
,
metastatic non-small-cell lung cancer
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
Mon, 05/11/20 - 10:27 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
FDA
,
Enhertu
,
gastric cancer
,
breakthrough therapy
Daiichi Sankyo submits application for CAR T therapy axicabtagene ciloleucel to treat patients with certain relapsed/refractory B-cell lymphomas in Japan
Pharmaceutical Business Review
Tue, 03/31/20 - 11:05 am
Tags:
Daiichi Sankyo
,
Japan
,
CAR-T
,
axicabtagene ciloleucel
,
relapsed or refractory diffuse large B-cell lymphoma
Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
Fierce Biotech
Wed, 03/25/20 - 10:49 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
Enhertu
,
clinical trials
,
HER2-positive non-small cell lung cancer
AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch
Fierce Pharma
Mon, 02/10/20 - 11:42 pm
Tags:
AstraZeneca
,
Daiichi Sankyo
,
clinical trials
,
FDA
,
Enhertu
,
cancer
,
breast cancer
Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
Tags:
antibody-drug conjugate
,
AstraZeneca
,
Daiichi Sankyo
,
Enhertu
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
Tags:
AstraZeneca
,
breast cancer
,
Daiichi Sankyo
,
trastuzumab deruxtecan
,
gastric cancer
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
Tags:
FDA
,
AstraZeneca
,
Daiichi Sankyo
,
advanced breast cancer
,
Enhertu
Daiichi, AstraZeneca breast cancer drug joins bumper crop of early FDA approvals
BioPharma Dive
Fri, 12/20/19 - 08:19 pm
Tags:
Daiichi Sankyo
,
AstraZeneca
,
FDA
,
drug approvals
,
breast cancer
,
trastuzumab deruxtecan
SABCS 2019 – Astrazeneca and Daiichi join the Her2 resistance
EP Vantage
Wed, 12/11/19 - 10:24 am
Tags:
breast cancer
,
AstraZeneca
,
Daiichi Sankyo
,
SABCS
,
trastuzumab deruxtecan
Seattle Genetics Claims Arbitration Rights in Daiichi Sankyo ADC Dispute
BioSpace
Tue, 12/3/19 - 10:29 pm
Tags:
Seattle Genetics
,
Daiichi Sankyo
,
antibody-drug conjugate
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Fri, 11/8/19 - 10:40 am
Tags:
Daiichi Sankyo
,
Exelixis
,
clinical trials
,
diabetic nephropathy
,
Minnebro
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Pharmaforum
Wed, 11/6/19 - 10:18 am
Tags:
Daiichi Sankyo
,
Seattle Genetics
,
breast cancer
,
AstraZeneca
,
trastuzumab deruxtecan
,
Herceptin
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Fierce Biotech
Tue, 11/5/19 - 10:34 am
Tags:
Daiichi Sankyo
,
Seattle Genetics
,
antibody-drug conjugate
,
AstraZeneca
,
DS-8201
Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny
Fierce Pharma
Mon, 11/4/19 - 07:27 pm
Tags:
Daiichi Sankyo
,
oncology
,
painkillers
,
opioids
,
opioid crisis
Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute
Pharmaceutical Business Review
Fri, 11/1/19 - 10:35 am
Tags:
Daiichi Sankyo
,
Sarah Cannon Research Institute
,
antibody-drug conjugate
,
DS-7300
,
clinical trials
,
solid tumors
Recent Job Cuts in the Biopharma Industry
BioSpace
Mon, 10/7/19 - 11:29 pm
Tags:
Tocagen
,
Sanofi
,
Amneal
,
Daiichi Sankyo
,
Integra Life Sciences
,
Aclaris
,
Bayer
,
Novartis
,
Illumina
,
Merck
,
Roche Molecular Systems
,
Prometheus Labs
,
layoffs
Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Tags:
Astellas
,
AML
,
Xospata
,
Europe
,
Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Tags:
Astellas
,
FDA
,
gilteritinib
,
Europe
,
AML
,
Daiichi Sankyo
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.